Vaccine Processing Materials From BSE Countries To Be Removed By 2001
Executive Summary
Bovine-derived materials used in vaccine manufacturing will be sourced only from countries determined to be free of bovine spongiform encephalopathy within the next year, FDA Office of Vaccines Research & Review Acting Director William Egan, PhD, said July 27.
You may also be interested in...
FDA’s 2002 Regulatory Agenda, In Brief
IRB registration: FDA to propose rule requiring institutional review boards to register with the agency. Registration information would include name of institution operating the IRB, detailed contact information for "the senior officer of the institution and IRB chair or contact, the range of active protocols...involving FDA-regulated products reviewed in previous calendar year, and a description of the types of...products reviewed." The rule is intended to "make it easier for FDA to inspect IRBs and to convey information to IRBs," HHS' Unified Agenda for 2002 explains. FDA is also endorsing a voluntary IRB accreditation system...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011